Hassan H. Alhassan - Publications

Green-synthesized ZnO-MnO nanocomposite as a potent antimicrobial and antibiofilm agent: protein leakage mechanism and synergistic interaction with cefotaxime.

Journal: Frontiers in microbiology

Published: April 09, 2026

Aegeline mitigates isoproterenol-induced myocardial infarction: insights from biochemical, histopathological, and in silico studies.

Journal: Frontiers in cardiovascular medicine

Published: February 05, 2026

Ultrastructural Features of Gold Nanoparticle Interactions with T47D Spheroids.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Design, synthesis, in silico studies, and antiproliferative activity of a novel series of thiazole/1,2,3-triazole hybrids as apoptosis inducers and multi-kinase inhibitors endowed with anti-breast cancer activity.

Journal: RSC advances

Published: October 04, 2025

Computational prioritization of deleterious human myelin protein zero gene mutations reveals structural disruption and potential myelin dysfunction through dynamic simulations and stability analysis.

Journal: Journal of biomolecular structure & dynamics

Published: October 03, 2025

Correction: Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax.

Journal: Scientific reports

Published: September 03, 2025

The dual role of glycogen synthase kinase-3 beta (GSK3β) in neurodegenerative pathologies: interplay between autophagy and disease progression.

Journal: Frontiers in pharmacology

Published: August 27, 2025

Evaluating AI performance in infectious disease education: a comparative analysis of ChatGPT, Google Bard, Perplexity AI, Microsoft Copilot, and Meta AI.

Journal: Frontiers in medicine

Published: August 04, 2025

Drug-induced headache reports: a comprehensive disproportionality and time-to-onset pharmacovigilance study using the FAERS database (2018-2024).

Journal: Frontiers in pain research (Lausanne, Switzerland)

Published: July 21, 2025

A network pharmacology and in silico approach to target NEU1-mediated microglial activation in neuroinflammation: Validation in an LPS-induced mouse model.

Journal: Computers in biology and medicine

Published: May 01, 2025

Elucidation of Artemisinin as a Potent GSK3β Inhibitor for Neurodegenerative Disorders via Machine Learning-Driven QSAR and Virtual Screening of Natural Compounds.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 28, 2025

Integrative machine learning and molecular simulation approaches identify GSK3β inhibitors for neurodegenerative disease therapy.

Journal: Scientific reports

Published: March 21, 2025